A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Condition:   Hepatitis B, Chronic Interventions:   Drug: JNJ-73763989;   Drug: JNJ-56136379;   Drug: Placebo for JNJ-73763989;   Drug: Placebo for JNJ-56136379;   Drug: Entecavir (ETV) monohydrate;   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Tenofovir alafenamide (TAF) Sponsor:   Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials